A Novel Approach towards Medical Entity Recognition in Chinese Clinical Text.

Journal: Journal of healthcare engineering
Published Date:

Abstract

Medical entity recognition, a basic task in the language processing of clinical data, has been extensively studied in analyzing admission notes in alphabetic languages such as English. However, much less work has been done on nonstructural texts that are written in Chinese, or in the setting of differentiation of Chinese drug names between traditional Chinese medicine and Western medicine. Here, we propose a novel cascade-type Chinese medication entity recognition approach that aims at integrating the sentence category classifier from a support vector machine and the conditional random field-based medication entity recognition. We hypothesized that this approach could avoid the side effects of abundant negative samples and improve the performance of the named entity recognition from admission notes written in Chinese. Therefore, we applied this approach to a test set of 324 Chinese-written admission notes with manual annotation by medical experts. Our data demonstrated that this approach had a score of 94.2% in precision, 92.8% in recall, and 93.5% in F-measure for the recognition of traditional Chinese medicine drug names and 91.2% in precision, 92.6% in recall, and 91.7% F-measure for the recognition of Western medicine drug names. The differences in F-measure were significant compared with those in the baseline systems.

Authors

  • Jun Liang
    Department of AI and IT, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China.
  • Xuemei Xian
    Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang Province 310000, China.
  • Xiaojun He
    Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang Province 310000, China.
  • Meifang Xu
    Zhejiang University International Hospital, Hangzhou, Zhejiang Province 310000, China.
  • Sheng Dai
    Chemical Sciences Division , Oak Ridge National Laboratory , Oak Ridge , Tennessee 37831 , USA . Email: dais@ornl.gov.
  • Jun'yi Xin
    Hangzhou Medical College, Hangzhou, Zhejiang Province 310000, China.
  • Jie Xu
    Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang Province 310000, China.
  • Jian Yu
    Key laboratory of Transplantation, Chinese Academy of Medical Sciences, Tianjin, 300192, China; Tianjin Key Laboratory for Organ Transplantation, Tianjin First Center Hospital, Tianjin, 300192, China; Department of Liver Transplantation, Tianjin Medical University First Center Clinical College, Tianjin, 300192, China; Tianjin Key Laboratory of Molecular and Treatment of Liver Cancer, Tianjin First Center Hospital, Tianjin, 300192, China.
  • Jianbo Lei
    Clinical Research Center, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, People's Republic of China.